COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Aspirin Resistance Reversibility in Diabetic Patients (ARRDM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01935193
Recruitment Status : Unknown
Verified August 2013 by Marta Bisi, Azienda Ospedaliera San Giovanni Battista.
Recruitment status was:  Recruiting
First Posted : September 5, 2013
Last Update Posted : September 5, 2013
Information provided by (Responsible Party):
Marta Bisi, Azienda Ospedaliera San Giovanni Battista

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Actual Primary Completion Date : August 2013
Study Completion Date : No date given
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 January 13, 2015
January 16, 2015